Search

everythinglearnresearchcommunity

for

Search:↓

10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

5% minoxidil foam is a safe, effective treatment for male pattern hair loss, with increased hair count and few side effects.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Trichoscopy helps tell apart hair loss due to alopecia areata from trichotillomania in eyebrows.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning, especially for skin and hair symptoms.

Hair transplanting is a useful, often overlooked treatment for female pattern hair loss.

Researchers found markers that can tell if hair has been bleached, which could improve hair test accuracy.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Dissecting cellulitis of the scalp is a condition that causes inflammation and scarring on the scalp, mainly affecting African-American men, and can lead to permanent hair loss.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Low-cost videomicroscopes might not be reliable for examining scalp disorders compared to standard methods.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

New skin imaging, teledermatology, and AI could become key in future dermatology care.

The ABCA4 gene protects hair follicle stem cells from toxic vitamin A byproducts.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.